Media stories about Neogen Corporation (NASDAQ:NEOG) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Neogen Corporation earned a news sentiment score of 0.04 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 46.1551963978296 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
These are some of the news stories that may have effected Accern Sentiment Analysis’s scoring:
- Analysts Anticipate Neogen Corporation (NEOG) to Announce $0.34 EPS (americanbankingnews.com)
- Global Rodenticides Market Report 2017-2022 – BASF SE (Germany), Bayer AG (Germany) (mynewsdesk.com)
- Veterinary Molecular Diagnostics Market is Projected to Grow Steadily During (2016-2024) (reports.pr-inside.com)
- Latin America superdisintegrants market insights shared in detailed report (whatech.com)
- Bacterial Cell Culture Market by 2022: Future Strong Projections for Forthcoming Years (emailwire.com)
Neogen Corporation (NASDAQ NEOG) traded down $0.40 on Friday, hitting $81.92. 27,211 shares of the company were exchanged, compared to its average volume of 111,867. The company has a market capitalization of $3,127.97, a price-to-earnings ratio of 68.81, a P/E/G ratio of 4.17 and a beta of 1.53. Neogen Corporation has a one year low of $58.96 and a one year high of $82.62.
Neogen Corporation (NASDAQ:NEOG) last issued its earnings results on Tuesday, September 19th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.30 by $0.01. The company had revenue of $95.30 million for the quarter, compared to analysts’ expectations of $94.87 million. Neogen Corporation had a net margin of 12.28% and a return on equity of 9.93%. Neogen Corporation’s quarterly revenue was up 14.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.26 EPS. analysts predict that Neogen Corporation will post 1.31 EPS for the current year.
A number of research analysts have recently issued reports on NEOG shares. Zacks Investment Research cut shares of Neogen Corporation from a “buy” rating to a “hold” rating in a report on Thursday, August 24th. BidaskClub cut shares of Neogen Corporation from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Finally, CL King started coverage on shares of Neogen Corporation in a report on Friday, July 14th. They set a “neutral” rating for the company.
ILLEGAL ACTIVITY WARNING: “Neogen Corporation (NEOG) Earns Daily Coverage Optimism Rating of 0.04” was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://sportsperspectives.com/2017/11/10/neogen-corporation-neog-earns-daily-coverage-optimism-rating-of-0-04.html.
In other news, VP Terri A. Morrical sold 11,398 shares of the company’s stock in a transaction dated Wednesday, September 27th. The shares were sold at an average price of $75.01, for a total value of $854,963.98. Following the sale, the vice president now directly owns 28,185 shares of the company’s stock, valued at approximately $2,114,156.85. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Edward Bradley sold 6,372 shares of the company’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $70.05, for a total transaction of $446,358.60. Following the completion of the sale, the vice president now directly owns 75,156 shares in the company, valued at $5,264,677.80. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 149,210 shares of company stock worth $11,168,321. 4.20% of the stock is owned by insiders.
Neogen Corporation Company Profile
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Receive News & Ratings for Neogen Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen Corporation and related companies with MarketBeat.com's FREE daily email newsletter.